Harvard Study Highlights Risk of False Negatives in RNAi Screening

A meta-analysis of several genome-wide, cell-based Drosophila RNAi screens, in conjunction with a focused RNAi screen, indicated that the rate of false negatives in such experiments is at least 8 percent.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.